Monday, September 15, 2014 6:49:05 PM
eugeneseymourmd@mac.com
4:47 PM (1 hour ago)
to me
This is really getting scary!
I’m afraid that no vaccine nor drug currently out there is going to work well because of the extensive mutation of the virus that has occurred so far.
A fellow I know is completely convinced that this means the end of the world. He’s established a redoubt in Santa Fe where he can be totally self-sufficient for up to a year. He asked me how long this could last. I have no idea but the mathematical models aren’t encouraging.
Senator Harkin is holding a hearing on the issue tomorrow in Washington.
Besides vaccines and drugs, there needs to be extremely accurate data collection so that predictions can be made as to the area of further spread. In that manner, preventative interventions can take place. That assumes, of course, an ideal world but unfortunately, the state of healthcare in the impacted countries leaves much to be desired.
Remember that plague swept throughout Europe in waves killing almost one third of the population in total….and it started small!
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
On Sep 15, 2014, at 12:02 PM, I wrote:
It was posted this AM - no problem!
BTW, break a leg in Aspen and I don't mean skiing!
Me
On Mon, Sep 15, 2014 at 11:10 AM, <eugeneseymourmd@mac.com> wrote:
Now this one is scary!
http://www.wired.com/2014/09/r0-ebola/?mbid=social_fb
forgive me if I’ve sent this before
http://www.nytimes.com/2014/09/13/world/africa/us-scientists-see-long-fight-against-ebola.html?_r=1
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM